Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide. - El Fakiri M; Regupathy AR; Uhlmann L; Ayada N; Geis NM; Domogalla LC; Lahdenranta J; Blakeman B; Wood F; Meyer PT; Huxley P; Eder M; et al. (Theranostics, 2024)